Fibrinogen ß chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism.

Klajmon, Adrianna; Chmiel, Jakub; Zabczyk, Michal; Pociask, Elzbieta; Wypasek, Ewa; Malinowski, Krzysztof P; Undas, Anetta; Natorska, Joanna

Klajmon, Adrianna; Chmiel, Jakub; Zabczyk, Michal; Pociask, Elzbieta; Wypasek, Ewa; Malinowski, Krzysztof P; Undas, Anetta; Natorska, Joanna.

Afiliação

Klajmon A; John Paul II Hospital, Krakow, Poland.
Chmiel J; Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Zabczyk M; John Paul II Hospital, Krakow, Poland.
Pociask E; Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Wypasek E; Department of Biocybernetics and Biomedical Engineering, AGH University of Science and Technology, Krakow, Poland.
Malinowski KP; John Paul II Hospital, Krakow, Poland.
Undas A; Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
Natorska J; Department of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Krakow, Poland.

Eur J Clin Invest ; 52(4): e13718, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34783023

Assuntos

Coagulação Sanguínea/fisiologia; Fator XIII/genética; Fibrina/fisiologia; Fibrinogênio/genética; Polimorfismo Genético; Embolia Pulmonar/sangue; Embolia Pulmonar/genética; Doença Aguda; Idoso; Feminino; Humanos; Masculino; Pessoa de Meia-Idade

Palavras-chave

factor XIII; fibrin clot; fibrinogen; polymorphism; pulmonary embolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Embolia Pulmonar / Coagulação Sanguínea / Fator XIII / Fibrinogênio / Fibrina Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google